Table 5 The 20 sponsors with the most number of interventional clinical trials.
From: TrialBench: Multi-Modal AI-Ready Datasets for Clinical Trial Prediction
Sponsor | # of trials |
|---|---|
GlaxoSmithKline | 3017 |
National Cancer Institute (NCI) | 2826 |
Pfizer | 2346 |
M.D. Anderson Cancer Center | 2099 |
AstraZeneca | 2095 |
Novartis Pharmaceuticals | 2071 |
Mayo Clinic | 1911 |
Cairo University | 1835 |
National Institute of Allergy and Infectious Diseases (NIAID) | 1758 |
Massachusetts General Hospital | 1725 |
Merck Sharp & Dohme LLC | 1691 |
Boehringer Ingelheim | 1689 |
Assistance Publique - Hôpitaux de Paris | 1686 |
Eli Lilly | 1678 |
Hoffmann-La Roche | 1575 |
University of California, San Francisco | 1404 |
Stanford University | 1323 |
Duke University | 1301 |
Sanofi | 1267 |
Memorial Sloan Kettering Cancer Center | 1253 |
